Clinically, patients with IgA-producing B cell infiltration tend to have poorer survival in CRC and melanoma, and high level of intratumoral IgA associates with shorter survival in bladder cancer​ [197, 212–215]. Here, CD79A is linked to colorectal carcinoma.